Europe Warehouse High Quality thymalin Peptide Powder Vials 79621-14-0

  Product Detail  

Thymalin is a biologically active peptide that’s generated significant interest in recent years due to its immunomodulatory effects. Derived from the thymus gland, the peptide was first discovered and characterised in 1977; however, it was only recently that scientists began to investigate the compound as a treatment for autoimmune diseases and immunodeficiency conditions. It even has the potential to support ageing immune systems.

Initial research appears to show that thymalin acts directly on the thymus gland, mimicking naturally occurring peptides. The thymus gland is responsible for T-cell development (a crucial type of lymphocyte). Central to the adaptive immune system, supporting thymus function could help activate more T cells, restoring immune function in otherwise compromised individuals.

While the early results look promising, further research into the regenerative effects of thymalin is needed. That being said, the peptide is already being used to treat some conditions related to immune deficiency, chronic infections, and autoimmune disorders.

What is Thymalin?

Thymalin is a polypeptide medication that’s produced synthetically for medical research and treatment. Derived from the thymus gland, this peptide compound acts directly on the thymus gland, stimulating enhanced thymic activity and increasing the production of particular white blood cells. [1]

To understand thymalin, we must first understand the thymus gland. Located in the upper chest, this gland orchestrates the development and maturation of a specialist class of white blood cells called T lymphocytes or T cells. These cells are the mainstay of the adaptive immune system, detecting pathogenic antigens and responding in a well-coordinated defense. [2]

The use of thymalin peptide in clinical treatments has shown promising results in improving the function of T-cells. By stimulating the thymus gland and enhancing the production of these immune cells, thymalin helps in boosting the body’s defense mechanisms, making it particularly beneficial for patients suffering from various immune disorders, including those who are immunocompromised. [3] The treatment has been researched and used extensively in Russia and other countries, where it is recognized as a vital tool for immune modulation. [1] [3]

Thymalin peptide therapy is often used to treat immune dysfunctions and assist patients with weakened immune systems, including those recovering from severe infections like COVID-19. The therapeutic effects of thymalin peptide are attributed to its ability to increase the number of functional immune cells, which in turn aids in quicker recovery and reduces the severity of infections. [4]

How Does Thymalin Work?

The molecular mechanism behind thymalin’s immunoprotective action is due to the effects of short peptides in its composition. These short peptides bind to double-stranded DNA and/or histone proteins, regulating gene expression, synthesising immune system proteins, stimulating stem cell differentiation, and activating gerontogenes. [5]

Taken together, thymalin increases and speeds up the process of T cell development. Indeed, as one study found, thymalin reduced the expression of CD44 and CD117 by 2-3 times and increased the expression of CD28 by 6.8 times. As the authors concluded, “This indirectly indicates that thymalin stimulated differentiation of CD117 cells into mature CD28 T lymphocytes.” [3]

Other studies have noted an anti-inflammatory component to its mechanism of action. Thymalin was heavily investigated for COVID-19, finding that thymalin treatment normalized proinflammatory cytokine levels, preventing the deleterious “cytokine storm” present in some COVID-19 patients. [6]

Positive Effects of Thymalin

Thymalin, as an immunomodulatory agent, is primarily used to support failing or diminished immune systems. During the COVID-19 pandemic, thymalin was heavily investigated as a potential treatment, reigniting the search for medical uses despite over three decades without success. [4]

Because COVID-19 led to lower levels of helper T cells, suppressor T cells, and regulatory T cells (especially in severe cases), thymalin was suggested as a possible solution. The compound also counteracts ‘cytokine storm syndrome’ seen in COVID-19, which plays a significant role in the most severe cases. [4]

Thymalin was found to reduce mortality in COVID-19 patients as well as counteract the low levels of T cells seen in immunodeficiency and autoimmune diseases. It also has a protective role in the lungs, enhancing anti-inflammatory and inhibiting proinflammatory cytokines. [4]

In addition to these COVID-19-related effects, thymalin has the following benefits:

• Immune Booster. The most important effect of thymalin is its potential to enhance the existing immune system, particularly the adaptive response. It, therefore, has an important function in immune disorders like HIV, which suppress the immune system, or autoimmune diseases such as rheumatoid arthritis. The treatment has also been used as an adjunct therapy in clinical practices for patients infected with influenza, hepatitis B and C viruses, herpes simplex, and HIV. [7]
• Increase Lifespan. The anti-ageing properties could potentially include improving skin elasticity and reducing the appearance of wrinkles. In the longest human clinical trial involving therapeutic peptides, 266 patients aged over 60 were given either nothing, Epithalon, thymalin, or both. The results found that patients taking some form of thymalin saw a reduction in acute respiratory disease, mortality, heart disease, high blood pressure, and osteoporosis compared to the control (Fig 1.). [8]
• Anti-Inflammatory Properties. Due to COVID-19, thymalin’s ability to dampen down the immune system’s response to infections once again became common knowledge. In 2008, thymalin was noted to prevent the accumulation of several proinflammatory cytokines, including IL-1 beta, IL-2, IL_6, TNF-alpha, interferon-gamma, and anti-inflammatory cytokine IL-10. This was instrumental in counteracting the cytokine storm present in severe COVID-19 cases. [9]
• Pain Reduction. Some evidence exists suggesting that thymalin (or at least thymalin analogues) can provide analgesic benefits. In a 2002 study, PAT (peptide analogue of thymalin) demonstrated an equal analgesic effect compared to potent medications like dexamethasone and indomethacin. As the paper concluded, “The anti-hyperalgesic and anti-inflammatory effects of PAT can be attributed, at least partially, to the downregulation of proinflammatory mediators.” [10]

Fig. 1 Effect of thymalin and epithalamin on the state of immune, endocrine systems, and metabolism as measured by the homeostasis stability coefficient, a measure of bodily performance where 100% HSC corresponded to the norm.  * – P<0.01; ** – P<0.001, as compared to the baseline level for this group; # – P<0.001, as compared to the analogous index for the control group.

First and foremost, thymalin is known as an immunomodulator – even its analgesic effects are, in part, related to this effect. However, recent research has indicated several possible benefits. [10]

Other surprising consequences of thymalin include:

• Anti-Hair Loss. According to one study, thymalin and zinc are highly effective combinations for restoring lost hair. The mixture is applied to the scalp and any bald patches, forcing the hair to enter the anagen phase of hair growth. Indeed, thymic peptides naturally exert a hair growth-modulatory effect, triggering hair growth. In one study, zinc-thymalin saw significant improvements in hair growth in regions with previous “absent hair.” [11]
• Antitumour Agent. Initial results from a Russian study noted “pronounce antitumour effects” from thymalin against a transplanted sarcoma in male rates. [12] Another study in females with advanced cervical carcinoma also noted that thymalin immunotherapy and radiotherapy worked better than radiotherapy alone. [13] However, a Cochrane review of all thymic peptides found no evidence of antitumour effects. [14]

Thymalin Dosages

Thymalin dosages vary significantly from study to study. Due to limited long-term data, we haven’t got a reliable estimate of dosage that’s safe for several years.

Usually, thymalin is administered in a dosage range of 1 mg to 10 mg either intramuscularly or subcutaneously every day for a set period, e.g., 10 days. For example, in a COVID-19 study, thymalin was given in the form of 10 mg/2 mL 0.9% NaCl intramuscular injections every day for 10 days. [4]

According to Russian pharmaceutical manufacturer Cosmic Nootropic ( Discount Code EP10), the correct dosages by age are as follows:

The medication should be given every day intramuscularly or subcutaneously for 3-10 days and can only be repeated (if necessary) after 1 to 6 months. These dosages are confirmed by RuPharma, which also notes that when used for preventative purposes, the recommended dosage is 1-10 mg for adults  3-5 days.

However, it should be noted that the efficacy of thymalin is heavily dependent on the presence of zinc. If a patient experiences a zinc deficiency, then thymalin will be substantially less effective.

Potential side effects of thymalin include restlessness (akathisia) and irritability or mood instability. Compared to other peptides, it has an incredibly mild side effect profile. That being said, it is not advised for women who are breast-feeding or pregnant. Always consult your physician before starting any new supplement or regimen.

The Role of Thymalin Peptide in Treating COVID-19 Patients

Thymalin has been explored as a potential treatment for COVID-19, especially in the context of immune dysfunction and recovery from severe symptoms. The ongoing COVID-19 pandemic has placed significant strain on healthcare systems worldwide, with millions of patients affected by the virus. In particular, severe cases of COVID-19 often lead to immune dysregulation, where the body’s immune system either overreacts or fails to respond appropriately, causing severe symptoms like respiratory distress and chest complications. [4]

Research has shown that thymalin can support the recovery of patients with COVID-19 by helping to restore normal immune function. Studies have indicated that thymalin may contribute to the normalization of immune cell activity, reducing the inflammatory response associated with severe infections. As COVID-19 often leads to a disruption in immune function, the role of thymalin in improving immune cell response is crucial in managing the disease and preventing long-term complications. [4]

In fact, the peptide has shown significant promise in alleviating symptoms of severe COVID-19, particularly in patients who experience chronic respiratory problems or other immune-related issues. In a study published in a medical journal, thymalin peptide was shown to help COVID-19 patients recover faster, with a noticeable reduction in symptoms and improvement in lung function. [4]

The Future of Thymalin Peptide Use

As research into thymalin peptide continues to evolve, its potential applications in treating various diseases, including immune dysfunction and COVID-19, are becoming more apparent. The growing body of clinical evidence supports its use as an adjunctive therapy for patients suffering from severe infections, autoimmune disorders, and immune-related diseases. With the COVID-19 pandemic still ongoing in many parts of the world, thymalin may serve as an important tool in the fight against viral infections. [3] [4]

Thymalin’s ability to modulate immune responses and help restore immune function is a promising prospect for those dealing with compromised immune systems. Additionally, its potential benefits in treating conditions such as COVID-19, respiratory distress, and other immune-related complications further solidify its role in modern medicine. [4]

As more clinical trials are conducted and additional research emerges, thymalin peptide is likely to become a key player in the treatment of immune dysfunction, with potential applications in various therapeutic areas, from chronic disease management to post-viral recovery. For patients struggling with weakened immune systems, thymalin peptide may offer hope for improved recovery and improved quality of life.

Final Thoughts

Thymalin presents a powerful therapy for bolstering immune systems in people with immunodeficiency, autoimmune disease, or age-related immune decline. This potent peptide has been the subject of research for several decades; however, it was during the COVID-19 pandemic that it reemerged as a potential treatment, strengthening the adaptive immune system and lowering the risk of a cytokine storm.

Several studies have found that thymalin works directly on the thymus gland, mirroring similar natural peptides. Due to a complex interplay of receptors and molecules, thymalin increases the development and maturation of T lymphocytes. It also modulates the inflammatory response, normalizing proinflammatory cytokine levels.

Overall, thymalin’s role in immunomodulation and its broad potential applications make it an intriguing candidate for further study and clinical use. Its ability to support immune function, reduce inflammation, and even provide anti-ageing benefits highlights its versatility. Continued research and clinical trials will be crucial in understanding the full spectrum of its benefits and potential side effects.

With growing interest in peptide therapies, thymalin could become a significant tool in managing immune-related conditions and promoting overall health and longevity.